Development Expense Annual Chart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Some of its early clinical data look much better than expected.

Apr 6, 2021 at 6:20AM Follow @jimhalley Johnson & Johnson (NYSE:JNJ) is the very definition of a value stock: five consecutive years of annual revenue growth, an above-average dividend that has been raised for 58 consecutive years in a row, and a diversified product portfolio capable of weathering various lawsuits, pandemics, and whatever else gets thrown its way. Last week, it was reported that a batch of 15 million doses of the company's vaccine that was being made for Johnson & Johnson by Emergent BioSolutions (NYSE:EBS) had to be thrown out because a m...

These trends illuminate why investors place such a premium on ServiceNow's shares.

Author Bio Reuben Gregg Brewer believes dividends are a window into a company's soul. He tries to invest in good souls. The stock market is usually pretty good at discounting the future, but sometimes investors get a little too pessimistic. That appears to be what is going on at global industrial giant Here's a quick look at why long-term investors might want to put this stock on their wish lists anyway. A valuable opportunity Shares of 3M are about breakeven for the year, which is actually not so bad given the coronavirus pandemic. That said, the SPDR S&P 500 ETF as...